Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Stronger Neo-Minophagen C injection

Marketed by Dexa Medica

Ingredients in every 20 ml

Glycyrrhizic acid 40 mg
Glycine 400 mg
L-Cysteine 20 mg

Each package contains

30 ampoules of 20 ml

Dosage form

injection

Dosage formInjection

Flavour

None

W.H.O. classification

A05C
A05C

A.T.C. Level 1

Anatomical Main group

A - Alimentary tract and metabolism
A05C

A.T.C. Level 2

Therapeutic subgroup

A05 - Bile and Liver Therapy Drugs
A05C

A.T.C. Level 3

Pharmacological subgroup

A05C - Drugs for Bile Therapy and Lipotropics in Combination

Available in

Indonesia

Warnings

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CONSULT YOUR DOCTORSafety of this item for use while operating heavy machinery has not been established. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTORSafety of this item for use during pregnancy has not been established. Please consult your doctor.

Lactation

CONSULT YOUR DOCTORSafety of this item for use during lactation has not been established. Please consult your doctor.

Indication

Improvement of abnormal hepatic function in chronic hepatic diseases.

Dosage

OTHER DETAILS
In chronic hepatic diseases, the daily dosage is from 40 to 60 ml once a day by intravenous injection or intravenous drip infusion. The dosage may be adjusted depending on patient's age and symptom. If an increased dosage is necessary, the daily dosage should be kept within the limit of 100 ml.

In the experience of the clinical use, the occuring frequency of the adverse reactions such as hypokalemia tends to be higher in the elderly. Careful administration shold be required with observation of patient's condition.